Skip to main content
. Author manuscript; available in PMC: 2012 Aug 13.
Published in final edited form as: Mol Pharmacol. 1996 Sep;50(3):512–521.

TABLE 1. Binding characteristics of wild-type and mutant human A2A-adenosine receptors using the antagonist radioligand [3H]XAC.

Data are presented as mean ± standard deviation of two or three independent experiments, each performed in duplicate. Each sample contained 7–11 μg of membrane protein/tube. Agonist and antagonist binding affinities [Ki values, structures in Fig. 2 and Jacobson et al., (35)] were determined in 3H]XAC (1.0 nM) competition binding studies using membrane homogenates prepared from transiently transfected COS-7 cells, as described in Experimental Procedures. Ki values were calculated from IC50 values by using the KaleidaGraph program. All constructs contain an HA-tag sequence at the amino terminus (15).

Construct
Compound Wild-type T88A T88S 188R
Bmax (pmol/mg) [3H]XAC 14.9 ± 1.2 6.54 ± 1.61b 6.26 ± 070b 5.54 ± 0.47b
Kd (nM) [3H]XAC 8.83 ± 1.46 10.8 ± 18d 5.76 ± l.82d 4.21 ± 1.17c
Ki (nM) Agonists
 CADO 118 ± 22 16,400 ± 3,200c 776 ± 313c 9,140 ± 2,590c
 DPMA 65.5 ± 0.3 5,710 ± 2,520c 655 ± 134c 4,090 ± 760c
 NECA 19.1 ± 1.7 1,590 ± 280c 778 ± 224c 2,660 ± 1,390c
 CGS 21680 26.7 ± 6.5 22,100 ± 2,900b 422 ± 180c 4,620 ± 620b
Antagonists
 CGS 15943 1.20 ± 0.30 7.98 ± 1.71c 6.28 ± 1.68c 5.00 ± 052b
 ZM 241385 0.758 ± 0.135 3.47 ± 2.41d 1.16 ± 0.20d 2.00 ± 0.71d
a

p <0.001.

b

p <0.01.

c

p <0.05.

d

Not significant.